
==== Front
Microbiology (Reading)
Microbiology (Reading)
micro
micro
Microbiology
1350-0872
1465-2080
Microbiology Society

39302176
001487
10.1099/mic.0.001487
Research Article
Biotechnology and Synthetic Biology
Use of Rgg quorum-sensing machinery to create an innovative recombinant protein expression system in Streptococcus thermophilus
http://orcid.org/0000-0003-3150-8555
Gardan Rozenn 1*rozenn.gardan@inrae.fr

Honvo-Houeto Edith 1edith.honvo-houeto@inrae.fr

Mézange Christine 1christine.mezange@inrae.fr

http://orcid.org/0000-0001-9088-2235
Maillot Nathanael Jean 1Nathanael.maillot@inrae.fr

http://orcid.org/0000-0003-1701-4241
Balvay Aurélie 1aurelie.balvay@inrae.fr

http://orcid.org/0000-0002-4603-2038
Rabot Sylvie 1sylvie.rabot@inrae.fr

http://orcid.org/0000-0001-7525-3131
Bermúdez-Humarán Luis G. 1luis.bermudez@inrae.fr

http://orcid.org/0000-0001-5960-4341
Langella Philippe 1philippe.langella@inrae.fr

http://orcid.org/0000-0001-7438-5618
Monnet Véronique 1veronique.devys@gmail.com

http://orcid.org/0000-0003-4388-3010
Juillard Vincent 1vincent.juillard@inrae.fr

1 Paris-Saclay University, INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France
The authors declare no conflicts of interest.

RozennGardan, rozenn.gardan@inrae.fr
Supplement: One supplementary figure and three supplementary tables are available with the online version of this article.

2024
20 9 2024
170 9 00148729 5 2024
01 8 2024
Copyright © 2024 The Authors
2024
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.

Abstract

Streptococcus thermophilus holds promise as a chassis for producing and secreting heterologous proteins. Used for thousands of years to ferment milk, this species has generally recognized as safe (GRAS) status in the USA and qualified presumption of safety (QPS) status in Europe. In addition, it can be easily genetically modified thanks to its natural competence, and it secretes very few endogenous proteins, which means less downstream processing is needed to purify target proteins, reducing costs. Extracellular degradation of heterologous proteins can be eliminated by introducing mutations that inactivate the genes encoding the bacterium’s three major surface proteases. Here, we constructed an inducible expression system that utilizes a peptide pheromone (SHP1358) and a transcriptional regulator (Rgg1358) involved in quorum-sensing regulation. We explored the functionality of a complete version of the system, in which the inducer is produced by the bacterium itself, by synthesizing a luciferase reporter protein. This complete version was assessed with bacteria grown in a chemically defined medium but also in vivo, in the faeces of germ-free mice. We also tested an incomplete version, in which the inducer had to be added to the culture medium, by synthesizing luciferase and a secreted form of elafin, a human protein with therapeutic properties. Our results show that, in our system, protein production can be modulated by employing different concentrations of the SHP1358 inducer or other SHPs with closed amino acid sequences. We also constructed a genetic background in which all system leakiness was eliminated. In conclusion, with this new inducible expression system, we have added to the set of tools currently used to produce secreted proteins in S. thermophilus, whose myriad applications include the delivery of therapeutic peptides or proteins.

inducible promoter
heterologous protein production
Rgg
signalling peptide
Streptococcus thermophilus
Paris-Saclay precompetitive IDEX-2017 Juillard Vincent TWB Precompetitive project Juillard Vincent INRAE Applicable Not
==== Body
pmcIntroduction

In the realm of biotechnology, heterologous protein production is most often carried out using Escherichia coli or Bacillus species as bacterial hosts. However, there is a pressing need to develop other bacterial chassis given that host choice strongly influences potential applications. At present, the two domains of greatest importance are the in vitro production of proteins and the in situ delivery of proteins with therapeutic properties. A significant hurdle in this work is that it is almost impossible to predict the fate and yield of a given heterologous protein in a specific host, especially when the protein must undergo secretion and/or may experience protease-mediated maturation/degradation [1]. For pharmaceutical applications, lactic acid bacteria (LAB) are of particular interest because they have been granted generally recognized as safe (GRAS) status by the U.S. Food and Drug Administration (FDA) and qualified presumption of safety (QPS) status by the European Food and Safety Authority (EFSA). For example, Lactococcus lactis has been successfully used to deliver anti-inflammatory molecules to treat inflammatory bowel disease (IBD) at the mucosal level [2]. However, there are some drawbacks to employing L. lactis, including its significant residual levels of cell surface proteolysis; the latter occurs even in strains that lack the major extracellular protease HtrA [3]. Furthermore, only a few strains of L. lactis are somewhat naturally competent, which constrains potential genetic modifications [45]. Therefore, there is a need to find hosts other than L. lactis.

Streptococcus thermophilus is one of the main starters used in yoghurt and cheese production and is emerging as a promising cell factory [6], especially for producing heterologous proteins. Its combined traits make it a good candidate host. First, S. thermophilus is naturally competent [79], allowing for straightforward genetic modifications; it is also a non-sporulating bacterium with a small genome [10]. Second, it can be grown under tightly controlled conditions in milk, rich media or chemically defined media, a trait that could facilitate protein production at different scales. Third, in S. thermophilus, surface proteolysis is carried out by three proteases, facilitating the creation of mutant strains in which there is no cell surface proteolysis [11], a property that could be useful when producing secreted proteins. However, to date, S. thermophilus has been used to produce just a few heterologous proteins, namely those of a cytoplasmic nature, such as green fluorescent or luciferase reporter proteins [12, 13]. Fourth, because this bacterium remains metabolically active during gastrointestinal transit [1415], strains that produce bacterial surface-anchored or secreted proteins could be used to (1) induce vaccination by activating the host immune response or (2) promote certain physiological effects in the gastrointestinal tract. As a proof of concept that this species could be used to produce cell-wall-anchored proteins, Lecomte et al. successfully expressed the gene encoding the Lactobacillus helveticus prtH protease in S. thermophilus; no protease activity was detected in the resulting supernatant [16].

To efficiently produce a heterologous protein, the gene encoding the protein must be placed under the control of a specific promoter. Depending on the protein, it may be useful to choose among constitutive promoters (with different strengths) [17] or inducible promoters [12], especially when the protein produced has a negative impact on the growth of the bacterial host. Blomqvist et al. built a pheromone-induced expression vector [18] using a bacteriocin production mechanism found in S. thermophilus. This quorum-sensing (QS) mechanism, named StbABCDHR, functions with the extracellular detection of the peptide pheromone StbC. Using the stbD gene promoter, the researchers confirmed that the system could be induced by the presence of mature synthetic StbC in the extracellular medium. However, the inducible promoter was shown to be leaky (i.e. significant levels of expression occurred in the inducer’s absence). Very recently, a tetracycline-inducible promoter was developed in L. lactis and was successfully tested in S. thermophilus [13]. That said, at present, a limited number of promoters are available and have been tested in S. thermophilus.

Other QS mechanisms are present in S. thermophilus, and they function based on intracellular pheromone detection. Indeed, pheromones are detected inside cells after exportation, maturation and internalization [19]. Upon arrival in the intracellular environment, pheromones interact with dedicated transcriptional regulators, a process that modifies their activity and, consequently, the expression of target genes. The ComS/ComR system, in which ComS is the pheromone, controls the mechanism that triggers natural competence, which is required for transformation [2021]. Similarly, SHP/Rgg systems, in which SHP is the pheromone, control different functions including the production of post-translationally modified peptides [2223]. In this study, we utilized the SHP/Rgg1358 system from S. thermophilus strain LMD-9 to develop an inducible protein expression system employing the promoter Pster1357. This choice was based on the fact that, in S. thermophilus, promoter-based SHP/Rgg systems, there are only transcription of the SHP encoding gene and the operon found downstream of the rgg gene [24]; in contrast, in ComR systems, there is transcription of an extended regulon [25]. We validated the functionality of our inducible expression system by producing a luciferase reporter and a secreted form of elafin, a human protein. We found that our system could be finely controlled by modulating inducer concentrations, and we constructed a genetic background in which all system leakiness was eliminated. Finally, we showed that the system is fully functional in vivo – it successfully produced luciferase in the faeces of germ-free mice.

Methods

Bacterial strains and growth conditions

We used the wild-type (WT) S. thermophilus strain LMD-9 [26] as a chromosomal DNA donor to recover the shp/rgg1358 system by PCR (Fig. 1) and the WT strain CNRZ1066 [10] as the host for the different genetic constructions. The S. thermophilus strains used in this study are listed in Table 1. S. thermophilus strains were grown at 42 °C in either M17 medium (Difco) supplemented with 10 g l−1 lactose (M17lac) or in a chemically defined medium (CDM) [27]. E. coli strains TG1repA+ [8] or TOP10 (Thermofischer scientific) and L. lactis strain MG1363 [28] were used as hosts for intermediary cloning steps. E. coli strains were grown in Luria-Bertani (LB) broth with shaking at 30 °C for strain TOP10 and at 37 °C for strain TG1repA+. L. lactis strains were grown at 30 °C in M17 medium (Difco) supplemented with 10 g l–1 glucose. Agar (1.5%) was added to the media as needed. When required, antibiotics were added to the media at the following final concentrations: erythromycin at 150 µg ml−1 for E. coli and at 5 µg ml−1 for S. thermophilus and L. lactis, kanamycin at 1 mg ml−1 for S. thermophilus, spectinomycin at 150 µg ml−1 for S. thermophilus, and chloramphenicol at 10 µg ml−1 for E. coli, S. thermophilus and L. lactis.

Fig. 1. Schematic representation of the SHP/Rgg1358 quorum-sensing mechanism in S. thermophilus strain LMD-9 and of the genetic constructs used in the study. (a) The quorum-sensing signal is a pheromone encoded by the shp1358 gene. SHP1358 is a small hydrophobic peptide, whose mature form is produced by the cleavage of a precursor and then exported; the two processes are performed by the endopeptidase Eep and the transporter PptAB, respectively. At high cell densities, secreted SHP1358 is reimported into the cell by the Ami transporter and then interacts with the regulatory protein Rgg1358. When the resulting SHP/Rgg1358 complex binds to the promoter region of the two target genes, Pshp1358 and Pster1357, it activates their transcription. (b) DNA constructs encoding the complete or truncated SHP/Rgg1358 system were fused to the luciferase-encoding gene (luxAB) or the elafin-encoding gene (names of corresponding strains on the right). The solid arrows represent genes (orientation and name underneath). The hatched arrows represent reporter or heterologous protein-encoding genes. The broken arrows represent promoters (name at head of arrow). Blue broken arrows represent promoters regulated by Rgg1358.

Table 1. Streptococcus thermophilus strains used in this study

Strain*	Genotype	Resistance†	Description‡	Source or reference	
LMD-9	Wild-type	-	-	[26]	
CNRZ1066	Wild-type	-	-	[10]	
TIL1486	ΔpptAB::erm	Erm	-	[24]	
TIL1523	ΔsepM::spec	Spec	PCR fragment sepM::spec → CNRZ1066	This study	
TIL1524	blp::shp-rgg1358-Pster1357-luxAB-aphA3	Km	pGICB004a::shp-rgg1358-Pster1357→ CNRZ1066	This study	
TIL1525	blp::rgg1358-Pster1357-luxAB-aphA3	Km	pGICB004a::rgg1358-Pster1357→ CNRZ1066	This study	
TIL1535	ΔhtrA::aphA3	Km	PCR fragment htrA::aphA3 → CNRZ1066	This study	
TIL1536	ΔhtrA::aphA3 ΔsepM::spec	Km Spec	TIL1535 DNA → TIL1523	This study	
TIL1551	blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec	Km Spec Cm	pEla:: shp-rgg1358-Pster1357→ TIL1536	This study	
TIL1552	blp::rgg1358-Pster1357-elafin- P32cat ΔhtrA::aphA3 ΔywdF::spec	Km Spec Cm	pEla::rgg1358-Pster1357→ TIL1536	This study	
TIL1566	blp::rgg1358-Pster1357-luxAB-aphA3 ΔpptAB::erm	Km	pGICB004a::rgg1358-Pster1357→ TIL1486	This study	
TIL1567	blp::rgg1358-Pster1357- elafin- P32cat ΔhtrA::aphA3 ΔywdF::spec ΔpptAB::erm	Km Erm	TIL1486 DNA → TIL1552	This study	
TIL1664	blp::P32-luxAB- aphA3	Km	pGICB004a::P32→ CNRZ1066	This study	
TIL1672	blp::luxAB- aphA3	Km	pGICB004a→ CNRZ1066	This study	
a *All strains TIL strains are derived from strain CNRZ1066.

b†Km, Spec, Cm and Erm: resistance to kanamycin, spectinomycin, chloramphenicol and erythromycin, respectively.

‡The arrows indicate construction via transformation with chromosomal DNA, PCR fragment or a plasmid.

DNA manipulation and sequencing

Restriction enzymes, T4 DNA ligase (New England Biolabs) and Phusion DNA polymerase (Finnzymes) were used according to the manufacturers’ instructions. Standard methods were used to carry out DNA purification, restriction digestion, PCR, ligation and sequencing. The oligonucleotides used (Eurofins) are listed in Table S1, available in the online version of this article. S. thermophilus strain CNRZ1066 or its derivatives were transformed using natural competent cells [8] prepared with the addition of synthetic competence peptide (ComS, LPYFAGCL) at a final concentration of 1 µM. L. lactis electrocompetent cells were prepared and transformed as previously described [29]. The plasmids used are listed in Table S2.

Synthesis of SHP and ComS peptides

The peptide SHP1358 (EGIIVIVVG), also named SHP3, was purchased from Chinapep and the peptides ESIIVIAVG (SHP1), EGIIVILVG (SHP4), EGIIVIGVG (SHP5), CIYTIVGGV (SHP8), DIIIIVGG (SHP9) and ComS from Genecust. The purity of the peptides was greater than 95%. SHP peptides were resuspended as 1 mM stock in DMSO for SHPs and water for ComS. Substocks (100 µM) were made in water for both types of peptides before their final dilution and utilization in CDM. All stock solutions were stored at −20 °C.

Construction of mutant strains

The surface protease mutant strain was obtained on the basis of strain CNRZ1066, in which one of the proteases (PrtS) is naturally lacking, as follows: the overlapping PCR method was used to delete the sepM (STR_RS07745) and htrA (STR_RS09505) genes and replace them with a spectinomycin (spec) and a kanamycin cassette (aphA3), respectively, as previously described [8]. The oligonucleotides are described in Table S1. Briefly, the spec and the aphA3 cassettes were PCR amplified from pAT28 [30] and pKa [31] plasmids, respectively, as DNA template. The upstream and downstream fragments of sepM and htrA genes were amplified using chromosomal DNA from strain CNRZ1066 as a template. The upstream fragments, the cassettes and the downstream fragments were fused by overlapping PCR. The resulting PCR fragments were used to transform strain CNRZ1066, leading to the construction of strain TIL1523 (sepM::spec) and strain TIL1535 (htrA::aphA3). Strain TIL1536 (sepM::spec htrA::aphA3) was constructed by transforming strain TIL1523 with chromosomal DNA from strain TIL1535.

We constructed two versions of our inducible expression system: a complete one working on its own and a truncated one that requires the addition of synthetic SHP in the culture medium to trigger expression. To study the relevance of our inducible expression systems, we used luxAB luciferase-encoding genes, and thus two derivatives of plasmid pGICB004a, pGICB004a::shp-rgg1358-Pster1357 (complete version) and pGICB004a::rgg1358-Pster1357 (truncated version), were constructed as follows: the shp-rgg1358-Pster1357 fragment was PCR amplified with oligonucleotides FusLuxCplt-SpeI and FusLux-EcoRI using chromosomal DNA from strain LMD9 as a template; double digested with SpeI and EcoRI restriction enzymes; and finally ligated into pGICB004a between the related restriction sites leading to the construction of plasmid pGICB004a::shp-rgg1358-Pster1357 . A similar approach was used for the construction of pGICB004a::rgg1358-Pster1357 with oligonucleotides FusLuxIncplt-SpeI and FusLux-EcoRI. Both plasmids were linearized by ScaI. The linearized plasmid pGICB004a::shp-rgg1358-Pster1357 was used to transform strain CNRZ1066 leading to strain TIL1524 (blp::shp-rgg1358-Pster1357-luxAB) and linearized plasmid pGICB004a::rgg1358-Pster1357 was used to transform strains CNRZ1066 and TIL1486 (ΔpptAB::erm) leading to strains TIL1525 (blp::rgg1358-Pster1357-luxAB) and TIL1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB::erm). To construct strain TIL1664 used as a positive control for the in vivo experiment, plasmid pGICB004a::P32 was linearized by ScaI and used to transform strain CNRZ1066. To construct strain TIL1672 used as a negative control for the in vivo experiment, plasmid pGICB004a was linearized by ScaI and used to transform strain CNRZ1066.

To study the functionality of our inducible expression systems, we decided to clone and express a protein of therapeutic interest, elafin [3233]. For this, we constructed plasmids pEla::shp-rgg1358-Pster1357 and pEla::rgg1358-Pster1357 by replacing the luxAB genes and aphA3 cassette in plasmids pGICB004a::shp-rgg1358-Pster1357 and pGICB004a::rgg1358-Pster1357 by the elafin-encoding gene and a chloramphenicol cassette (P32cat), as follows: the elafin gene was PCR amplified with oligonucleotides FusEla-EcoRI_For and FusEla_Rev from plasmid pLB386 (ProbiHôte collection, Micalis Institute, INRAE, unpublished data). The chloramphenicol cassette was amplified with oligonucleotides P32Cat_For and P32Cat-SalI_Rev from plasmid pNZ5319 [34]. The elafin and the chloramphenicol cassette fragments were joined by overlapping PCR, double digested with SalI and EcoRI restriction enzymes, and finally ligated into plasmids pGICB004a::shp-rgg1358-Pster1357 and pGICB004a::rgg1358-Pster1357 between the related restriction sites leading to the construction of pEla::shp-rgg1358-Pster1357 and pEla::rgg1358-Pster1357. Both plasmids were linearized by ScaI and used to transform strain TIL1536 (ΔhtrA::aphA3 ΔsepM::spec) leading to strain TIL1551 (blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec) and strain TIL1552 (blp::rgg1358-Pster1357 -luxAB ΔhtrA::aphA3 ΔywdF::spec). Chromosomal DNA from strain TIL1486 (ΔpptAB::erm) was used to transform strain TIL1552 leading to strain TIL1567 (blp::rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec ΔpptAB::erm).

All constructions were confirmed by PCR and sequenced when necessary.

Luciferase assays

For kinetic experiments, cells were grown overnight at 42 °C in CDM. These cultures were then diluted in 50 ml of CDM to an optical density at 600 nm (OD600) of 0.05 and incubated at 42 °C. Aliquots of 1 ml of cultures were sampled at regular time intervals until the culture reached the stationary phase and analysed as follows: OD600 was measured with 1 ml of culture, then 10 µl of a 0.1% nonyl-aldehyde solution was added and luminescence was immediately measured with a Junior LB9509 (Berthold Technologies). Induction of luxAB-encoding genes in strain TIL1525 was performed with the addition of SHP1358 peptide (EGIIVIVVG) in the growth medium at a final concentration of 1 µM. Similarly, for the luminescence measurement of faeces, 10 µl of a 0.1% nonyl-aldehyde solution was added to 1 ml of a 10−2 dilution of the faeces in CDM.

For characterization of the inducibility of the SHP/Rgg1358 system with different concentrations of SHP1358 peptide or with different SHP peptides, precultures of strain TIL1566 were grown at 37 °C in CDM. The cultures were then diluted to an OD600 of 0.05. At the beginning of the cultures, synthetic SHP1358 peptide was added at a concentration ranging between 0 and 10 µM and the other SHP synthetic peptides were added at a concentration of 1 µM. Then, 250 µl of the cultures were transferred to the wells of a sterile white microplate covered with a transparent bottom (Greiner). For characterization of the responsiveness of strain TIL1566 toward the inducer during its growth, SHP1358 peptide was added every hour for 3 h directly in the wells of the microplate. The OD600 and luminescence values of the cultures were monitored at 37 °C every 10 min using an Inﬁnite M200 spectroluminometer (Tecan), as previously described [9]. Results were reported as relative luminescence units divided by OD600 (RLU/OD600).

Fig. 2. Levels of growth and luciferase luminescence for S. thermophilus strains grown under different conditions. (a) TIL1524 (blp::shp-rgg1358-Pster1357-luxAB) in CDM (◯), (b) TIL1525 (blp::rgg1358-Pster1357-luxAB) in CDM (◊) or in CDM to which synthetic SHP1358 had been added (final concentration of 1 µM) 2 h after the beginning of culture growth (♦), and (c) TIL1525 in CDM (◊) and TIL 1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB) in CDM (Δ). The growth curves (OD600) are depicted using dotted lines, and the relative levels of luciferase luminescence (RLU/OD600) are depicted using solid lines. Data shown are representative of three independent experiments.

Fig. 3. Levels of growth and/or luciferase luminescence for the leakage-free strain, TIL1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB::erm), grown under different conditions. (a) Maximum relative levels of luciferase luminescence (RLU/OD600) during strain growth in CDM across a range of SHP1358 (SHP3) concentrations (0–10 µM). Strain TIL1524 (blp::shp-rgg1358-Pster1357-luxAB) was used as a control. The data shown are the means±sd of the results from four independent experiments. (b) Strain growth (OD600) and luciferase luminescence (RLU/OD600) in CDM to which SHP1358 was added at different time points; the coloured curves (•) show the results of SHP1358 being added at different time points, and the grey curves (×) show the results of the situations where no SHP1358 was added. The growth curves are depicted using dotted lines, and the relative levels of luciferase luminescence are depicted using solid lines. Data shown are representative of three independent experiments. (c) Maximum relative levels of luciferase luminescence (RLU/OD600) during strain growth in CDM to which different SHPs had been added (1 µM). The data are the means±sd of the results from three independent experiments. To test for significant differences between the treatments and the control, one-way ANOVAs were performed, followed by Dunnett’s tests for multiple comparisons (**P<0.01; ****P<0.0001).

Western blot assays and elastase tests

For sample preparation of the Western blot assays, derivatives of strain CNRZ1066 were grown in CDM at 42 °C. When necessary, induction was performed by the addition of SHP1358 peptide (EGIIVIVVG) at a final concentration of 0.5 µM in the growth medium at an OD600 of 0.2. When the cultures reached the desired OD600 (depending on the experiment), 10 ml was centrifuged at 3200 g for 10 min at room temperature. The filtered supernatants (0.22 µM, Millex GV PVDF, Millipore) were further ultrafiltered through Amicon devices [Ultra-15 (3 kDA cutoff); Millipore] for 1 h at 25 °C at 3200 g. A volume of 500 µl containing the secreted elafin was recovered in the upper compartment of the Amicon device. Then, 10 µl of the samples was diluted in Laemmli Buffer (4×) and heated to 95 °C for 5 min. Samples were run on Precast Bis-Tris Gel 4–12% (NuPAGE 1.5 mm×10; Invitrogen) and transferred to nitrocellulose membranes (Trans–Blot turbo 0.2 µm PVDF; Bio-Rad). The membranes were blocked for 2 h at room temperature in a TBST solution (0.1 M Tris pH 7.5, 1.5 M NaCl, 1% Tween 20) containing 5% skimmed milk and then hybridized for 2 h at room temperature in TBST solution with anti-elafin antibodies (Santa Cruz sc-398075, 1:1000 dilution). Four washing steps were performed in TBST solution, one for 15 min and three for 5 min, and detection was achieved using secondary antibody coupled to peroxidase (Abliance BI2413C, 1:1000 dilution) for 1 h. Four washing steps were again performed as described above before the addition of a solution containing luminol (ECL prime; GE healthcare) for 5 min. Five microlitres of recombinant elafin (RD system, 1:100 dilution) was used as a control. Detection was finally recorded using a Chemidoc imaging system (Bio-Rad).

For sample preparation of the elastase assays (EnzChek elastase assay kit; Thermo Fisher Scientific), strains were grown in CDM until they reached an OD600 of 1. Supernatants were recovered via centrifugation (at 10 000 r.p.m. at 4 °C for 10 min), filtrated over a 0.22 µm filter (Millipore) and then ultrafiltered successively through 10 and 3 kDa cut-off Amicon filters in order to concentrate the supernatants 200 times. The elastase assays were then performed in accordance with the manufacturer’s instructions. Elastase activity was detected based on the fluorescence reading obtained at 485/530 nm (excitation/emission) from a Biotek SynergyMx microplate reader.

In vivo assays

Animals

Nine male and nine female C3H/HeN germ-free mice, 10–12 weeks old, were obtained from the germ-free rodent breeding unit of Anaxem (the germ-free animal facility of the Micalis Institute, INRAE, France). They were transferred into three flexible-film isolators (Getinge), which were ventilated with HEPA-filtered sterile air under positive pressure. The isolators were fitted with a DPTE aseptic transfer system (Getinge) allowing sterile connection of containers (Getinge) to import sterile consumables and germ-free mice. Inside each isolator, three male and three female mice were housed separately in collective cages (three mice per cage) containing sterile bedding made of wood shavings. The living environment was enriched with sterile shredding paper and gnawing wood sticks. The mice had free access to autoclaved tap water and a γ-irradiated (45 kGy) standard diet (R03; Scientific Animal Food and Engineering). The animal room was maintained at 20–24°C and kept on a 12 h light/dark cycle. The mice were examined daily to ensure they stayed healthy.

Design of animal studies

The mice were individually identified with electronic chips (IntelliBio) implanted under the skin in the interscapular region. As adaptive responses of S. thermophilus in the gut may be improved by lactose [35], this sugar was added to the drinking water (4.5%, w/v) throughout the experiment. On day 0 (D0), mice from a given isolator were inoculated intragastrically, using flexible gavage tubes, with 0.2 ml of a cell suspension of one of the following three strains: TIL1664 (blp::P32-luxAB- aphA3) (1.44×108 c.f.u. ml−1); TIL1524 (blp::shp-rgg1358-Pster1357-luxAB-aphA3) (5.15×108 c.f.u. ml−1); TIL 1672 (blp::luxAB- aphA3) (5.2×109 c.f.u. ml−1). Then, fresh faeces were collected from each mouse on D2–3, D7, D10 and D14 to monitor the establishment of the strain and the luciferase activity produced by the bacterial cells. The last day (D15), the mice were killed by cervical dislocation. Colonization of the three strains in the gastrointestinal tract was assessed by counts obtained by plating on M17lac plates dilutions of faeces (in CDM for 10−1 and 10−2 dilutions and in 0.1% tryptone for the following dilutions). The 10−2 dilution was used for a manual luciferase assay as described above.

Results

Choice of the SHP/Rgg1358 system for heterologous protein production in S. thermophilus

The S. thermophilus pangenome encodes at least nine SHP/Rgg systems and one stand-alone Rgg system (V. Juillard, unpublished data). On average, S. thermophilus strains contain five shp/rgg pairs; such is the case for the strains used in this study, LMD-9, which is a common model in genetic studies of this species, and CNRZ1066. When an RNA sequencing approach was applied to strain LMD-9, it highlighted the presence of two Rgg transcriptional regulators, Ster_RS06405 and Ster_RS06695, whose target genes were expressed at high levels when the QS system was functional and at low levels when the QS system was disrupted [24]. These target genes are located downstream of the two Rgg-encoding genes. Given the relative genetic organization of the shp and rgg genes, we decided to focus on the gene encoding Ster_RS06695 because the position of its locus facilitates the construction of genetic scaffolding for heterologous protein production systems. In contrast, at the locus containing the Ster_RS06405-encoding gene, the genes encoding Rgg and SHP are convergent and overlapping. The STER_RS06695 gene is hereafter designed as rgg1358 based on a primary annotation as Ster_1358 in NCBI [26] and the use of this annotation in previous publications. The SHP gene (hereafter, SHP1358 or SHP3) is not annotated in the NCBI database. This gene encodes a 23 aa peptide (MKKQILLTLLLVVFEGIIVIVVG), for which maturation occurs in front of the glutamate residue, releasing a 9 aa peptide (sequence underlined above). The maturation process is carried out by the membrane protease Eep [36], and secretion into the extracellular medium is performed by the transporter PptAB [24]. The mature peptide (also called the autoinducing peptide) is then imported by the Ami oligopeptide permease. Once inside the cell, the mature SHP1358 peptide can interact with the Rgg1358 peptide to positively control the expression of its target genes (1) shp1358, creating a positive feedback loop, and (2) a polycistronic operon whose first three genes are involved in the production and secretion of a cyclic peptide called streptide [3638] (Fig. 1a). The first gene of the operon, ster_1357, encodes the precursor of streptide. When the shp1358 gene has been eliminated from the system, the addition of synthetic mature SHP1358 to the culture medium can restore shp1358 expression in a dose-dependent manner [36]. The DNA sequence recognized by the SHP/Rgg1358 complex has been identified in the promoter region of the shp1358 gene and of the ster_1357 gene [36]. In conclusion, we chose to use the SHP/Rgg1358 complex in combination with the promoter of the streptide polycistronic operon (Pster1357) to construct an inducible expression system in an S. thermophilus strain that naturally lacks this system: CNRZ1066 [10].

Validation of the SHP/Rgg1358 inducible expression system in S. thermophilus strain LMD-9 using luciferase as a reporter

When validating the functionality of our SHP/Rgg1358 inducible expression system, we utilized luciferase as a reporter protein because it is straightforward to quantify luciferase luminescence. We took advantage of the natural competence of S. thermophilus to introduce all the constructs into the chromosome of each experimental strain. This localization led to greater recombinant stability and precluded the need for maintenance via antibiotics. Two forms of the system were assessed (Fig. 1b). The first form of the system consisted of the shp1358 gene, the rgg1358 gene and the promoter of the streptide operon, Pster1357, and was used to generate strain TIL1524 (blp::shp-rgg1358-Pster1357-luxAB). This version of the system was complete (i.e. self-inducible) and was expected to trigger the expression of the target gene under the control of the Pster1357 promoter during the mid-exponential growth phase. The second form of the system lacked the shp1358 gene and was used to generate strain TIL1525 (blp::rgg1358-Pster1357-luxAB). This version of the system was incomplete (i.e. truncated or inducible) since target gene expression required the addition of mature synthetic SHP1358 to the growth medium. As expected, when strain TIL1524 (blp::shp-rgg1358-Pster1357-luxAB) was grown in CDM, luciferase luminescence appeared during the mid-exponential growth phase, with relative levels peaking at the end of exponential growth (3.7±0.3×106 RLU/OD600; Fig. 2a). Strain TIL1525 (blp::rgg1358-Pster1357-luxAB) was grown in two different media: CDM and CDM with synthetic SHP1358 (Fig. 2b). When grown in the CDM with synthetic SHP1358, the strain rapidly displayed luciferase luminescence, with relative levels peaking at the end of the exponential growth phase (3.2±0.3×106 RLU/OD600). However, even in the CDM without SHP1358, there was a significant relative level of luciferase luminescence (1.5±0.2×106 RLU/OD600). Although strain CNRZ1066 naturally lacks an SHP/Rgg1358 system, its genome does encode five other SHP/Rgg systems that produce mature SHPs, some of them with sequences highly similar to those of SHP1358 (Table S3). It seems likely that, in strain TIL1525, these endogenous SHPs were interacting with heterologous Rgg1358 and thereby causing luciferase expression. To test this hypothesis, we introduced the reporter fusion of strain TIL1525 (blp::rgg1358-Pster1357-luxAB) into strain TIL1486 (ΔpptAB::erm). In the resulting strain, TIL1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB::erm), none of these endogenous SHPs could be exported, as confirmed by the complete absence of luciferase luminescence (Fig. 2c). These results indicate that the promoter leakiness or cross-induction by endogenous SHPs that was occurring in strain TIL1525 could be entirely eliminated by the introduction of the ΔpptAB construct. Also, as expected, when SHP1358 was added to the culture medium for the leakage-free strain (TIL1566), we were able to restore luciferase expression, as detailed below.

Induction of the SHP/Rgg1358 expression system is dose dependent

An important sign that an inducible expression system is functioning properly is that the expression of the genes under promoter control can be modulated by inducer concentration. Thus, to assess the functionality of our SHP/Rgg1358 system, we grew strain TIL1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB::erm) in CDM to which different concentrations of SHP1358 had been added. In this experiment and the other luciferase production experiments described below, small-volume cultures (250 µl) were grown in microplates. We were able to tightly control maximum relative levels of luciferase luminescence between SHP1358 concentrations of 0 and 1 µM (Fig. 3a). Within this range, we did not observe any clear impacts of inducer concentration on strain growth (Fig. S1). At 10 µM, relative levels of luciferase luminescence exceeded those obtained with the self-inducible system (strain TIL1524), but variability among the biological replicates was also higher.

Another important sign of system functionality is that the expression of the genes under promoter control can be triggered rapidly at different time points during growth. Using strain TIL1566 (blp::rgg1358-Pster1357-luxAB ΔpptAB::erm), we conducted an experiment in which the treatment groups received SHP1358 at a final concentration of 1 µM at a given 60 min interval during culture growth (T=0, 60, 120, 180 or 240 min). When the addition of SHP1358 occurred at 0, 60 or 120 min, luciferase luminescence appeared immediately, and its levels rapidly increased (Fig. 3b). For these three treatment groups, maximum relative levels of luciferase luminescence were similar in magnitude at the end of the exponential growth phase. When the addition of SHP1358 occurred at 180 min, the maximum relative level of luciferase luminescence was lower, and, when it occurred at 240 min, no induction was seen. Unfortunately, it is impossible to interpret levels of luciferase luminescence after the late exponential growth phase because levels of FMNH2, luciferase’s cofactor, have declined, leading to luciferase inactivity [39].

Different SHPs can activate the SHP/Rgg1358 inducible expression system

As noted above, the presence of luminescence during growth by the strain with the truncated system (TIL1525: blp::rgg1358-Pster1357-luxAB) suggests that strain CNRZ1066 produces endogenous SHPs that can interact with Rgg1358. We thus conducted an experiment to test this hypothesis, to evaluate the efficacy of these potential endogenous SHPs as system inducers, and to assess whether target genes could be modulated by inducers other than SHP1358. The amino acid sequence of mature SHPs encoded by the genome of strain CNRZ1066 is described in Table S3. We thus grew the leakage-free strain with the truncated system (TIL1566: blp::rgg1358-Pster1357-luxAB ΔpptAB::erm) in CDM containing mature synthetic forms of these SHPs versus in CDM containing mature synthetic SHP1358 (SHP3) and then determined the maximum relative levels of luciferase luminescence. We found that three of these peptides had effects: SHP1, SHP4 and SHP5 (Fig. 3c). Maximum relative levels of luciferase luminescence were similar in response to SHP1 and SHP4 as they had been in response to SHP1358. SHP5 was less effective.

The SHP/Rgg1358 inducible expression system is functional in the gut of germ-free mice

Given its GRAS and QPS statuses, S. thermophilus is a good candidate for the in situ delivery of therapeutic molecules (e.g. peptides or proteins). To test the potential utility of our SHP/Rgg1358 inducible expression system in this context, we conducted an experiment using the strain with the complete system (TIL1524: blp::shp-rgg-Pster1357-luxAB). Strain TIL1664 (blp::P32-luxAB) was used as a positive control; its luciferase-encoding genes (luxAB) were under the control of P32, a strong constitutive promoter. The negative control was strain TIL1672 (blp::luxAB), whose luciferase-encoding genes were not under the control of a dedicated promoter. We chose to work with germ-free mice, whose gastrointestinal tracts are readily colonized by S. thermophilus (108 c.f.u. g−1 faeces) as long as lactose is added to the drinking water [40]. Germ-free mice were taken from a given isolator and inoculated intragastrically with one of the three strains. Their faeces was recovered four times over the course of 14 days to monitor bacteria abundance and relative levels of luciferase luminescence. The bacteria reached expected levels of abundance starting on day 7 [>8 log10 (c.f.u. g−1 faeces)] (Fig. 4a). At each sampling point, there were no significant differences in bacteria abundance among strains, but there were significant differences in the strains’ relative levels of luciferase luminescence (Fig. 4b). Luciferase luminescence levels were nearly null for the negative control (strain TIL1672); they reached around 3 log10 (RLU×10 000 c.f.u.−1) for the positive control (strain TIL1664). For the strain with the self-inducible system (TIL1524), luciferase luminescence was around 2 log10 (RLU×10 000 c.f.u.−1), indicating that the expression system was functioning in vivo, albeit at lower levels than those achieved with the strong constitutive promoter.

Fig. 4. Bacteria abundance and luciferase luminescence in the faeces of germ-free mice that had been inoculated with S. thermophilus strain TIL1664 (blp::P32-luxAB-aphA3) (black open circles), TIL1524 (blp::shp-rgg1358-Pster1357-luxAB-aphA3) (blue open circles) and TIL 1672 (blp::luxAB- aphA3) (red open circles). Faeces were sampled on days 2–3, 7, 10 and 14. (a) Counts (log10 c.f.u. g−1 faeces) were obtained by diluting and plating the faeces on M17lac. (b) Relative levels of luciferase luminescence (log10 RLU×10000 c.f.u. g−1 faeces) were measured using a 10−2 dilution of the faeces immediately after their dilution in CDM. To test for significant differences among treatments, repeated-measures two-way ANOVAs were conducted, followed by Tukey’s tests for multiple comparisons (*P<0.05; ***P<0.001; and ****P<0.0001).

The SHP/Rgg1358 inducible expression system can produce elafin

Elafin is an protease inhibitor found in the human gut and is known to display a protective effect against IBD [3341]. We thus tested the functionality of our inducible expression system by determining whether it could produce elafin. The luxAB genes and the aphA3 kanamycin cassette of the two plasmids pGICB004a::shp-rgg1358-Pster1357 and pGICB004a::rgg1358-Pster1357 were replaced by the elafin-encoding gene with upstream a DNA fragment encoding the secretion signal peptide (SP) of USP45 protein, the main secreted protein of L. lactis [42] and downstream a P32Cat cassette conferring resistance to chloramphenicol. Both of the resulting plasmids were linearized and used to transform strain TIL1536 (ΔhtrA::aphA3 ΔsepM::spec). This strain lacks the two major extracellular proteases found in S. thermophilus strain CNRZ1066 and displays reduced surface proteolytic activity, which should limit the degradation of secreted heterologous proteins [11]. Two strains were obtained: TIL1551, which had the complete form of the system (blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec), and TIL1552, which had the truncated form of the system (blp::rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec) (Fig. 1b). Next, both strains were grown in CDM. In the case of strain TIL1552, elafin expression was induced by adding SHP1358 at an OD600 of 0.2. Supernatant samples were recovered at different OD600 values, and the presence of elafin was determined using Western blot analysis. For the strain with the complete system (TIL1551), elafin was not detected at OD600=0.2 but was detected at OD600=0.5 (Fig. 5a) and OD600=1 (Fig. 5b). For the strain with the truncated system (TIL1552), when no SHP1358 was added, elafin was not detected at OD600= 0.2, started to be detected at OD600=0.5 (Fig. 5a) and was clearly detected at OD600=1 and 2 (Fig. 5b). At OD600=2, a faint band corresponding to an elafin degradation product was also seen . When SHP1358 was added, elafin levels at OD600=0.5 were much greater than in the absence of SHP1358 (Fig. 5a). This induction-related difference was less pronounced at OD600=1 and 2 (Fig. 5b). These results clearly highlight that induction was effective at OD600=0.5 during the mid-exponential growth phase, while also confirming the leakiness associated with the inducible promoter [i.e. in the absence of SHP1358, elafin was nonetheless present at higher OD600 values (1 and 2)]. To overcome this drawback, we introduced a ΔpptAB::erm construct into strain TIL1552, creating strain TIL1567 (blp::rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec ΔpptAB::erm). When this new strain was used, elafin was no longer detected at either OD600=0.5 or 1 in the absence of SHP1358 (Fig. 5c). However, as expected, the presence of elafin in the extracellular medium was restored when SHP1358 was added. We used strain TIL1536 as the negative control because it does not contain the elafin-encoding gene in its genome. As expected, no traces of elafin were found in any samples for this strain.

Fig. 5. Presence of elafin in the supernatant of different S. thermophilus strains as detected by Western blot. (a) At OD600=0.2 and 0.5 for strain TIL1536 (ΔhtrA::aphA3 ΔsepM::spec), TIL1551 (blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec) and TIL1552 (blp::rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec). (b) At OD600=1 and 2 for strain TIL1536, TIL1551 and TIL1552. (c) At OD600=0.2, 0.5 and 1 for strain TIL1567 (blp::rgg1358-Pster1357-luxAB-aphA3 ΔhtrA::aphA3 ΔywdF::spec ΔpptAB::erm). Purified elafin was the positive control, and supernatant from strain TIL1536 was the negative control (i.e. the strain does not produce elafin). Elafin production was induced by adding synthetic SHP (+SHP) to the culture medium at OD600=0.2.

Finally, we decided to determine whether the elafin produced and secreted by S. thermophilus was biologically active. To this end, we used a porcine pancreatic elastase assay, since elafin is a specific inhibitor of the elastase. Strain 1551 (blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec) was grown in CDM and supernatant was recovered at OD600=1 and concentrated 200 times. As a negative control, we used supernatant from strain 1536 (ΔhtrA::aphA3 ΔywdF::spec), which did not produce any elafin. As shown on Fig. 6, the concentrated supernatant of strain 1551 inhibited totally the activity of the elastase whereas the concentrated supernatant of strain 1 536 had no inhibitory effect. This result confirmed that strain TIL1551 secretes a biologically active elafin that is able to inhibit the activity of elastase.

Fig. 6. Elastase activity inhibition of the supernatant of strain TIL1551(blp::shp-rgg1358-Pster1357-elafin-P32cat ΔhtrA::aphA3 ΔywdF::spec) measured using an EnzChek elastase assay kit. Supernatants of strain TIL1536 (ΔhtrA::aphA3 ΔywdF::spec) and CDM were used as negative control. Ctrl+, positive control of the kit only containing the elastase enzyme and the fluorescent substrate, DQ elastin. Data shown are representative of three independent experiments.

Discussion

We have developed a new bacterial host chassis for producing high-quality heterologous proteins by introducing a QS system into S. thermophilus strain CNRZ1066.

First, we validated the functionality of a complete form of the system, which contained the gene encoding the SHP1358 pheromone, the gene encoding the Rgg1358 transcriptional regulator and the inducible Pster1357 promoter of the streptide operon. This system was used to produce two active compounds: an intracellular form of luciferase (origin: Photorabdus luminescens), whose luminescence is easy to detect during culture growth, and elafin, a secreted human protein with therapeutic properties. One advantage of our system is that it is self-inducible: heterologous protein production occurred immediately and rapidly during the mid-exponential growth phase under laboratory conditions. We also validated the functionality of our system in vivo: it successfully produced luciferase in the gut of germ-free mice, which indicates that it could potentially be used to deliver pharmaceuticals. These results are consistent with those of a previous study using R-IVET technology, in which researchers determined that two genes in the operon controlled by the Pster1357 promoter were specifically expressed under simulated conditions of human digestion [43]. The next step will be to assess levels of luciferase expression in the gut of mice with natural or humanized microbiota. Another advantage of our system is that it is localized in the chromosome, which ensures recombinant stability over time and precludes the need for maintenance via antibiotics; this contrasts with the situation of recombinant plasmids [44]. Indeed, levels of luciferase expression in vivo remained stable over a 14 day period.

Second, we explored the use of a truncated form of the system, which lacked the gene encoding the SHP1358 pheromone. Thus, its functionality was dependent on the addition of synthetic SHP1358 to the culture medium. We used this inducible version of the system to again produce luciferase and elafin. SHPs are easy to synthesize because they are linear nonapeptides with no post-translational modifications. The advantage of the system’s inducible form is that it does not impact the host bacterium’s physiology, as long as all nutritional requirements (e.g. amino acids, nitrogen or carbon) are met by the growth medium. We did detect leakiness – target protein expression in the absence of added SHP1358 – which we were able to completely eliminate via the inactivation of the pptAB genes. In S. thermophilus, the PptAB oligopeptide transporter seems to be devoted to exporting SHP-type pheromones and ComS, the competence peptide [24]. Surprisingly, we found that two peptides encoded by the genome of strain CNRZ1066 were as efficient as SHP1358 when used as synthetic inducers. It seems quite likely that at least one of these peptides is produced by strain CNRZ1066 and was thus responsible for cross-activating the inducible promoter. Interestingly, a third potential SHP of strain CNRZ1066, with an amino acid sequence close to the sequences of the two efficient SHPs, appeared to induce the system at low levels. Further work is needed to understand these differences in efficiency, such as affinity measurements between Rgg and SHPs. Thus, SHPs other than SHP1358 could be synthesized and then used to modulate heterologous protein production, depending on specific system applications. These findings also suggest that it may be possible to refine modulation by optimizing the sequence of the inducer, such as by using a synthetic peptide library. Finally, it would be interesting to explore the production of other heterologous proteins, especially those that could have a negative effect on S. thermophilus physiology and for which, therefore, the truncated system could prove particularly useful [45]. Indeed, during bacterial growth, we observed an immediate and rapid increase in luciferase production following the addition of the inducer, which indicates that growth (cell density) can be decoupled from protein production.

The SHP/Rgg1358 system is absent from approximately 50% of S. thermophilus strains. Therefore, it should be possible to introduce the complete or truncated system into the chromosome of one or more of these strains. Such could take place as in this study: the construct was introduced at the non-functional bacteriocin stb locus of S. thermophilus strain CNRZ1066 [46]. Alternative introduction sites include previously tested permissive loci, such as the tRNA serine and suc loci [47], or non-functional ORFs [48]. It is worth noting that, because some strains do not have any SHP/Rgg systems, cross-activation would be unlikely, making it unnecessary to delete the pptAB genes. For the remaining 50% of strains that naturally carry the SHP/Rgg1358 system, it would be possible to replace the streptide operon with a gene of interest at the homologous locus. This task could easily be accomplished using the Golden Gate Assembly technique, as long as naturally competent strains were used [13].

Functionality of the complete or truncated system is highly dependent on medium composition. In this regard, our system has a major advantage. First, the system was functional during growth in CDM devoid of peptides [49]. Second, the host bacterium, S. thermophilus, is a species that releases very few proteins and peptides into the extracellular medium during growth [11]. As a result of these two features, far less downstream processing would be needed to extract heterologous proteins from the extracellular medium, reducing downstream processing costs. In rich media, there are qualitative and quantitative effects of peptide composition, as illustrated by the fact that, for two different yeast extracts, there were two different levels of expression for two genes under the control of the streptide operon located downstream of ster1357 [50]. As their name suggests, these media are richer and make it possible to reach higher cell densities, which are also likely to result in higher protein yields.

In conclusion, our S. thermophilus chassis was not designed to compete with classical chassis (E. coli or B. subtilis) in terms of heterologous protein yields. However, this inducible expression system, which can be used in strains in which cell surface proteases have been inactivated, makes it possible to produce secreted proteins that will experience little to no degradation. More generally, this system adds to the existing suite of LAB chassis. It also exploits a bacterium that is naturally competent, thereby facilitating the introduction of genetic modifications. The dual GRAS–QPS status of S. thermophilus also means it can be used in certain targeted applications.

supplementary material

10.1099/mic.0.001487 Uncited Supplementary Material 1.

Acknowledgement

We thank Claire Maudet and Joane Louison from the Anaxem platform for their help with the mouse experiments. We are grateful to Jessica Pearce-Duvet for English language editing.

Abbreviations

CDM chemically defined medium

cfu colony forming unit

GRAS generally recognized as safe

IBD inflammatory bowel disease

LAB lactic acid bacteria

QPS qualified presumption of safety

QS quorum sensing

RLU relative luminescence units

SD standard deviation

WT wild type

Funding: This study was funded by the French National Institute for Agriculture, Food, and Environment (INRAE), a precompetitive project grant IDEX-2017 Paris-Saclay and a Toulouse White Biotechnology (TWB) precompetitive project grant.

Ethical statement: The Anaxem (the germ-free animal facility of the Micalis Institute, INRAE, France) licence number is: B78-322-6. All procedures involving mice were carried out in accordance with the European guidelines for the care and use of laboratory animals and approved by the ethics committee of the INRAE Research Centre at Jouy-en-Josas (approval reference, APAFIS no. 4947-2018061915332413 v1).
==== Refs
References

1. Terpe K Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems Appl Microbiol Biotechnol 2006 72 211 222 10.1007/s00253-006-0465-8 16791589
2. Bermúdez-Humarán LG Aubry C Motta J-P Deraison C Steidler L et al Engineering lactococci and lactobacilli for human health Curr Opin Microbiol 2013 16 278 283 10.1016/j.mib.2013.06.002 23850097
3. Guillot A Boulay M Chambellon É Gitton C Monnet V et al Mass spectrometry analysis of the extracellular peptidome of Lactococcus lactis: lines of evidence for the coexistence of extracellular protein hydrolysis and intracellular peptide excretion J Proteome Res 2016 15 3214 3224 10.1021/acs.jproteome.6b00424 27439475
4. David B Radziejwoski A Toussaint F Fontaine L de Frahan MH et al Natural DNA transformation is functional in Lactococcus lactis subsp. cremoris KW2 Appl Environ Microbiol 2017 83 e01074-17 10.1128/AEM.01074-17 28625996
5. Mulder J Wels M Kuipers OP Kleerebezem M Bron PA Unleashing natural competence in Lactococcus lactis by induction of the competence regulator ComX Appl Environ Microbiol 2017 83 e01320-17 10.1128/AEM.01320-17 28778888
6. Markakiou S Gaspar P Johansen E Zeidan AA Neves AR Harnessing the metabolic potential of Streptococcus thermophilus for new biotechnological applications Curr Opin Biotechnol 2020 61 142 152 10.1016/j.copbio.2019.12.019 31945498
7. Blomqvist T Steinmoen H Håvarstein LS Natural genetic transformation: a novel tool for efficient genetic engineering of the dairy bacterium Streptococcus thermophilus Appl Environ Microbiol 2006 72 6751 6756 10.1128/AEM.01156-06 17021227
8. Gardan R Besset C Guillot A Gitton C Monnet V The oligopeptide transport system is essential for the development of natural competence in Streptococcus thermophilus strain LMD-9 J Bacteriol 2009 191 4647 4655 10.1128/JB.00257-09 19447907
9. Fontaine L Boutry C de Frahan MH Delplace B Fremaux C et al A novel pheromone quorum-sensing system controls the development of natural competence in Streptococcus thermophilus and Streptococcus salivarius J Bacteriol 2010 192 1444 1454 10.1128/JB.01251-09 20023010
10. Bolotin A Quinquis B Renault P Sorokin A Ehrlich SD et al Complete sequence and comparative genome analysis of the dairy bacterium Streptococcus thermophilus Nat Biotechnol 2004 22 1554 1558 10.1038/nbt1034 15543133
11. Boulay M Metton C Mézange C Oliveira Correia L Meylheuc T et al Three distinct proteases are responsible for overall cell surface proteolysis in Streptococcus thermophilus Appl Environ Microbiol 2021 87 e0129221 10.1128/AEM.01292-21 34550764
12. Lecomte X Gagnaire V Lortal S Dary A Genay M Streptococcus thermophilus, an emerging and promising tool for heterologous expression: advantages and future trends Food Microbiol 2016 53 2 9 10.1016/j.fm.2015.05.003 26611164
13. Markakiou S Neves AR Zeidan AA Gaspar P Development of a tetracycline-inducible system for conditional gene expression in Lactococcus lactis and Streptococcus thermophilus . Microbiol Spectr 2023 11 e0066823 10.1128/spectrum.00668-23 37191512
14. Mater DD Bretigny L Firmesse O Flores M-J Mogenet A et al Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt FEMS Microbiol Lett 2005 250 185 187 10.1016/j.femsle.2005.07.006 16099606
15. Rul F Ben-Yahia L Chegdani F Wrzosek L Thomas S et al Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats J Biol Chem 2011 286 10288 10296 10.1074/jbc.M110.168666 21239485
16. Lecomte X Gagnaire V Briard-Bion V Jardin J Lortal S et al The naturally competent strain Streptococcus thermophilus LMD-9 as a new tool to anchor heterologous proteins on the cell surface Microb Cell Fact 2014 13 82 10.1186/1475-2859-13-82 24902482
17. Kong LH Xiong ZQ Song X Xia YJ Zhang N et al Characterization of a panel of strong constitutive promoters from Streptococcus thermophilus for fine-tuning gene expression ACS Synth Biol 2019 8 1469 1472 10.1021/acssynbio.9b00045 31117359
18. Blomqvist T Steinmoen H Håvarstein LS Pheromone-induced expression of recombinant proteins in Streptococcus thermophilus Arch Microbiol 2006 186 465 473 10.1007/s00203-006-0162-0 16932907
19. Neiditch MB Capodagli GC Prehna G Federle MJ Genetic and structural analyses of RRNPP intercellular peptide signaling of gram-positive bacteria Annu Rev Genet 2017 51 311 333 10.1146/annurev-genet-120116-023507 28876981
20. Fontaine L Wahl A Fléchard M Mignolet J Hols P Regulation of competence for natural transformation in streptococci Infect Genet Evol 2015 33 343 360 10.1016/j.meegid.2014.09.010 25236918
21. Talagas A Fontaine L Ledesma-García L Mignolet J Li de la Sierra-Gallay I et al Structural insights into streptococcal competence regulation by the cell-to-cell communication system ComRS PLoS Pathog 2016 12 e1005980 10.1371/journal.ppat.1005980 27907189
22. Bushin LB Clark KA Pelczer I Seyedsayamdost MR Charting an unexplored streptococcal biosynthetic landscape reveals a unique peptide cyclization motif J Am Chem Soc 2018 140 17674 17684 10.1021/jacs.8b10266 30398325
23. Capodagli GC Tylor KM Kaelber JT Petrou VI Federle MJ et al Structure–function studies of Rgg binding to pheromones and target promoters reveal a model of transcription factor interplay Proc Natl Acad Sci USA 2020 117 24494 24502 10.1073/pnas.2008427117 32907945
24. Lingeswaran A Metton C Henry C Monnet V Juillard V et al Export of Rgg quorum sensing peptides is mediated by the PptAB ABC transporter in Streptococcus thermophilus strain LMD-9 Genes 2020 11 1096 10.3390/genes11091096 32961685
25. Mignolet J Fontaine L Sass A Nannan C Mahillon J et al Circuitry rewiring directly couples competence to predation in the gut dweller Streptococcus salivarius Cell Rep 2018 22 1627 1638 10.1016/j.celrep.2018.01.055 29444418
26. Makarova K Slesarev A Wolf Y Sorokin A Mirkin B et al Comparative genomics of the lactic acid bacteria Proc Natl Acad Sci USA 2006 103 15611 15616 10.1073/pnas.0607117103 17030793
27. Letort C Juillard V Development of a minimal chemically-defined medium for the exponential growth of Streptococcus thermophilus J Appl Microbiol 2001 91 1023 1029 10.1046/j.1365-2672.2001.01469.x 11851809
28. Gasson MJ Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing J Bacteriol 1983 154 1 9 10.1128/jb.154.1.1-9.1983 6403500
29. Holo H Nes IF High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media Appl Environ Microbiol 1989 55 3119 3123 10.1128/aem.55.12.3119-3123.1989 16348073
30. Trieu-Cuot P Carlier C Poyart-Salmeron C Courvalin P A pair of mobilizable shuttle vectors conferring resistance to spectinomycin for molecular cloning in Escherichia coli and in Gram-positive bacteria Nucl Acids Res 1990 18 4296 10.1093/nar/18.14.4296 2143017
31. Trieu-Cuot P Courvalin P Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3’5’’-aminoglycoside phosphotransferase type III Gene 1983 23 331 341 10.1016/0378-1119(83)90022-7 6313476
32. Shaw L Wiedow O Therapeutic potential of human elafin Biochem Soc Trans 2011 39 1450 1454 10.1042/BST0391450 21936832
33. Motta J-P Bermúdez-Humarán LG Deraison C Martin L Rolland C et al Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis Sci Transl Med 2012 4 158ra144 10.1126/scitranslmed.3004212
34. Lambert JM Bongers RS Kleerebezem M Cre-lox-based system for multiple gene deletions and selectable-marker removal in Lactobacillus plantarum . Appl Environ Microbiol 2007 73 1126 1135 10.1128/AEM.01473-06 17142375
35. Mater DDG Drouault-Holowacz S Oozeer R Langella P Anba J et al Beta-galactosidase production by Streptococcus thermophilus is higher in the small intestine than in the caecum of human-microbiota-associated mice after lactose supplementation Br J Nutr 2006 96 177 181 10.1079/bjn20061724 16870007
36. Fleuchot B Gitton C Guillot A Vidic J Nicolas P et al Rgg proteins associated with internalized small hydrophobic peptides: a new quorum-sensing mechanism in streptococci Mol Microbiol 2011 80 1102 1119 10.1111/j.1365-2958.2011.07633.x 21435032
37. Schramma KR Bushin LB Seyedsayamdost MR Structure and biosynthesis of a macrocyclic peptide containing an unprecedented lysine-to-tryptophan crosslink Nat Chem 2015 7 431 437 10.1038/nchem.2237 25901822
38. Ibrahim M Guillot A Wessner F Algaron F Besset C et al Control of the transcription of a short gene encoding a cyclic peptide in Streptococcus thermophilus: a new quorum-sensing system? J Bacteriol 2007 189 8844 8854 10.1128/JB.01057-07 17921293
39. Bachmann H Santos F Kleerebezem M van Hylckama Vlieg JE Luciferase detection during stationary phase in Lactococcus lactis Appl Environ Microbiol 2007 73 4704 4706 10.1128/AEM.02807-06 17513590
40. Thomas M Wrzosek L Ben-Yahia L Noordine M-L Gitton C et al Carbohydrate metabolism is essential for the colonization of Streptococcus thermophilus in the digestive tract of gnotobiotic rats PLoS One 2011 6 e28789 10.1371/journal.pone.0028789 22216112
41. Bermúdez-Humarán LG Motta J-P Aubry C Kharrat P Rous-Martin L et al Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci Microb Cell Fact 2015 14 26 10.1186/s12934-015-0198-4 25889561
42. van Asseldonk M Rutten G Oteman M Siezen RJ de Vos WM et al Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363 Gene 1990 95 155 160 10.1016/0378-1119(90)90428-t 2123812
43. Uriot O Kebouchi M Lorson E Galia W Denis S et al Identification of Streptococcus thermophilus genes specifically expressed under simulated human digestive conditions using R-IVET technology Microorganisms 2021 9 1113 10.3390/microorganisms9061113 34064045
44. Del Carmen S de Moreno de LeBlanc A Martin R Chain F Langella P et al Genetically engineered immunomodulatory Streptococcus thermophilus strains producing antioxidant enzymes exhibit enhanced anti-inflammatory activities Appl Environ Microbiol 2014 80 869 877 10.1128/AEM.03296-13 24242245
45. Kim K Choe D Lee DH Cho BK Engineering biology to construct microbial chassis for the production of difficult-to-express proteins Int J Mol Sci 2020 21 990 10.3390/ijms21030990 32024292
46. Fontaine L Boutry C Guédon E Guillot A Ibrahim M et al Quorum-sensing regulation of the production of Blp bacteriocins in Streptococcus thermophilus . J Bacteriol 2007 189 7195 7205 10.1128/JB.00966-07 17693498
47. Knoops A Vande Capelle F Fontaine L Verhaegen M Mignolet J et al The CovRS environmental sensor directly controls the ComRS signaling system to orchestrate competence bimodality in Salivarius Streptococci mBio 2022 13 e0312521 10.1128/mbio.03125-21 35089064
48. Renye JA Somkuti GA Insertion of a heterologous gene construct into a non-functional ORF of the Streptococcus thermophilus chromosome Biotechnol Lett 2009 31 759 764 10.1007/s10529-009-9931-6 19172230
49. Monnet V Juillard V Gardan R Peptide conversations in gram-positive bacteria Crit Rev Microbiol 2016 42 339 351 10.3109/1040841X.2014.948804 25198780
50. Proust L Haudebourg E Sourabié A Pedersen M Besançon I et al Multi-omics approach reveals how yeast extract peptides shape Streptococcus thermophilus metabolism Appl Environ Microbiol 2020 86 e01446-20 10.1128/AEM.01446-20 32769193
